Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.

被引：0
|
作者：
Wang, Z. [1 ]
Han, Z. [1 ]
Tao, J. [1 ]
Chen, H. [1 ]
Sun, L. [1 ]
Tan, R. [1 ]
Gu, M. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Urol, Nanjing, Jiangsu, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B125
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [41] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [42] CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy
    Genvigir, Fabiana Dalla Vecchia
    Brayan Campos-Salazar, Antony
    Felipe, Claudia Rosso
    Tedesco-Silva Jr, Helio
    Medina-Pestana, Jose Osmar
    Doi, Sonia de Quateli
    Cerda, Alvaro
    Hirata, Mario Hiroyuki
    Herrero, Maria Jose
    Alino, Salvador Francisco
    Crespo Hirata, Rosario Dominguez
    PHARMACOGENOMICS, 2020, 21 (01) : 7 - 21
  • [43] INFLUENCE OF CYP3A5, CYP2C19 AND MDR1 GENETIC POLYMORPHISMS ON THE PHARMACOKINETICS OF CILOSTAZOL
    Kim, Se-Mi
    Park, Sun-Ae
    Kang, Hyun-Ah
    Cho, Hea-Young
    Shin, Sae-Byeok
    Lee, Yong-Bok
    DRUG METABOLISM REVIEWS, 2008, 40 : 151 - 151
  • [44] EFFECTS OF CYP2C19 GENOTYPES AND CYP3A4 INHIBITOR ERYTHROMYCIN ON VORICONAZOLE PHARMACOKINETICS
    Ouyang, Dong-sheng
    Shi, Hui-yan
    Zhou, Honghao
    DRUG METABOLISM REVIEWS, 2008, 40 : 30 - 31
  • [45] Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients
    Michelle Liu
    Savine Hernandez
    Christina L. Aquilante
    Kimberly M. Deininger
    Joann Lindenfeld
    Kelly H. Schlendorf
    Sara L. Van Driest
    The Pharmacogenomics Journal, 2024, 24
  • [46] Association of CYP3A5, CYP2C8, and ABCB1 Polymorphisms With Early Renal Injury in Chinese Liver Transplant Recipients Receiving Tacrolimus
    Deng, R.
    Liao, Y.
    Li, Yi
    Tang, J.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3258 - 3265
  • [47] Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro
    Stage, Tore Bjerregaard
    Graff, Magnus
    Wong, Susan
    Rasmussen, Louise Ladebo
    Nielsen, Flemming
    Pottegard, Anton
    Brosen, Kim
    Kroetz, Deanna L.
    Khojasteh, Cyrus
    Damkier, Per
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 510 - 519
  • [48] Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients
    Liu, Michelle
    Hernandez, Savine
    Aquilante, Christina L.
    Deininger, Kimberly M.
    Lindenfeld, Joann
    Schlendorf, Kelly H.
    Van Driest, Sara L.
    PHARMACOGENOMICS JOURNAL, 2024, 24 (02):
  • [49] Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Yang, Li-Jun
    Fan, Lan
    Liu, Zhao-Qian
    Mao, Yan-Mei
    Guo, Dong
    Liu, Li-Hui
    Tan, Zhi-Rong
    Peng, Liang
    Han, Chun-Ting
    Hu, Dong-Li
    Wang, Dan
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (06) : 601 - 608
  • [50] Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Tu, J. -H.
    Hu, D. -L.
    Dai, L. -L.
    Sun, Y.
    Fan, L.
    Zhang, M.
    Tan, Z. -R.
    Chen, Y.
    Li, Z.
    Zhou, H. -H.
    XENOBIOTICA, 2010, 40 (06) : 393 - 399
12345